SCHEMBL30824328

SCHEMBL30824328

COC(=O)c1ccc2c(c1)c(=O)[nH]c1[nH]c3ccncc3c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.64
CSNK2A1 P68400 3/20 0.64
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KIF11 P52732 2/20 0.45
DYRK1A Q13627 1/20 0.42
ROCK2 O75116 2/20 0.42
NAMPT P43490 1/20 0.42
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ROCK1 Q13464 1/20 0.40
CHEK1 O14757 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30824330 0.88 KDM4E (0.50) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL10134619 0.81 PARP1 (0.81) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL30824326 0.80 CSNK2A1 (0.53) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL30172793 0.79 PARP1 (0.74) PARP1CSNK2A1KIF11DYRK1AROCK2
SCHEMBL629270 0.78 PARP1 (1.00) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL30704691 0.78 PARP1 (1.00) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL2691509 0.78 PARP1 (0.90) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL6518381 0.76 AURKA (0.58) PARP1CSNK2A1KDM4EALDH1A1HPGD
SCHEMBL16377295 0.72 PARP1 (0.76) PARP1CSNK2A1KIF11DYRK1AROCK2
SCHEMBL6524053 0.71 AURKA (0.58) PARP1CSNK2A1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11926629-B1 Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11926629-B1 Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors CSNK2A3, CDK2, CSNK1G2 PARP1 1429/4885CSNK2A1 7/4885KDM4E 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.